A variant in CDKAL1 influences insulin response and risk of type 2 diabetesValgerður Steinthórsdóttir, Kāri Stefánsson, Unnur Styrkársdóttir et al.|Nature Genetics|2007Cited by 1.1k
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the USWilliam Yang Wang, Rong Xu, QuangQiu Wang et al.|Alzheimer s & Dementia|2024Cited by 140
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E.R. Butchbach, Mark E. Gurney|Human Molecular Genetics|2009Cited by 119